FDA Inspection 801108 — Grifols Biologicals LLC

Grifols Biologicals LLC — FEI 2080769

The FDA completed an inspection of Grifols Biologicals LLC on September 26, 2012 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 26, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)